We then determined the clinical relevance of CBX2 in osteosarcoma, we found that CBX2 expression was progressively increased gradually during osteosarcoma progression in patients with metastasis or recurrence (Figure 1E,F). The gene discussed is CBX2; the disease is osteosarcoma.